Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the fusion rate and clinical outcomes at 1 year of 20 patients with degenerative disc disease who undergo a Transforaminal Lumbar Interbody Fusion (TLIF) with the Stryker Tritanium Spinal System. This is an on-label, post-market outcomes study to build on the body of long-term evidence for the device.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03018392
Study type Interventional
Source Bone and Joint Clinic of Baton Rouge
Contact
Status Completed
Phase N/A
Start date January 2017
Completion date January 28, 2020

See also
  Status Clinical Trial Phase
Completed NCT01941563 - A Study of SI-6603 in Patients With Lumbar Disc Herniation Phase 3
Completed NCT02931279 - PASS OCT® Post-market Clinical Follow-up
Completed NCT02225444 - A Prospective Study of Instrumented, Posterolateral Lumbar Fusions (PLF) With OsteoAMP®
Completed NCT02421601 - A Study of SI-6603 in Patients With Lumbar Disc Herniation Phase 3
Terminated NCT02381067 - A Prospective Study of NuCel® in Cervical Spine Fusion N/A
Completed NCT01860417 - Treatment of Degenerative Disc Disease With Allogenic Mesenchymal Stem Cells (MSV) Phase 1/Phase 2
Completed NCT01513694 - Clinical Trial Based on the Use of Mesenchymal Stem Cells From Autologous Bone Marrow in Patients With Lumbar Intervertebral Degenerative Disc Disease Phase 1/Phase 2
Completed NCT02023372 - Efficacy Study of NuCel® in Patients Undergoing Fusion of the Lumbar Spine N/A